Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration (STAIRWAY)
Eye Disorder Macular Degeneration Neoangiogenesis Age-Related Macular Degeneration
For the latest version of this information please go to www.forpatients.roche.com